Jim Fong

Corporate Officer/Principal at CTI BIOPHARMA CORP.

62 year

Health Technology

Consumer Services

Jim Fong active positions

Companies	Position	Start	End
CTI BIOPHARMA CORP.	Corporate Officer/Principal	2007-12-31	-
CTI BIOPHARMA CORP.	Chief Operating Officer	2016-12-31	-

Companies	Position	Start	End
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Sales & Marketing	-	-

University of California, Los Angeles

Undergraduate Degree

International

United States

Operational

Chief Operating Officer	1
Corporate Officer/Principal	1
Undergraduate Degree	1

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.	Health Technology
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology

Private companies

Health Technology